Nutrition companies Royal DSM and Evonik announced their intention to establish a joint venture (JV) for omega-3 fatty acid products from natural marine algae for animal nutrition.
Evonik and DSM’s alternative omega-3 source will be aimed at initial applications in salmon aquaculture and pet food.
As part of the JV, the companies will together build a $200 million (€189.5 million) commercial-scale production facility in the United States.
DSM Nutritional Products and Evonik Nutrition & Care will each hold a 50 percent share in the joint venture and co-own the production facility, which will be built at an existing site of Evonik and is expected to come on stream in 2019.
The
